Interprofessional Care of Patients with Pulmonary Arterial Hypertension

To participate in this activity, please:

Log in Sign Up

A chronic, progressive disease that causes ongoing pulmonary vascular remodeling, pulmonary arterial hypertension (PAH) causes substantial patient burden beginning with significant diagnostic delay and declining physical function. Combination therapy with targeted agents is now recommended beginning at the time of diagnosis. Moreover, as recommended in current guidelines, the complex nature of PAH requires a multifaceted, holistic, and collaborative team-based approach to care. This activity highlights key concepts in managing patients with PAH, provides an overview of the principles of interprofessional collaboration, and describes the benefits and roles of members of an interprofessional, multidisciplinary care team for PAH.

Please visit our related course, Optimizing Outcomes in PAH: Evidence, Innovation, and Individualization, by clicking here.

Course Credit:

0.25 AAPA Category I CME Credit
0.25 ACPE Contact Hours
0.25 AMA PRA Category 1 CreditsTM
0.25 ANCC Contact Hours
0.25 CA-BRN Contact Hours

Dates:

Opens: 2026-05-15
Closes: 2027-05-15

Target Audience:

Nurse practitioners, pharmacists, physician associates, and physicians who provide care to patients with pulmonary arterial hypertension

This activity was self-funded by Annenberg Center for Health Sciences.

Accreditation Information

Accreditation

In support of improving patient care, the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 0.25 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

The Annenberg Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 hours AAPA Category 1 CME credits. Approval is valid until May 15, 2027. Physician Associates should only claim credit commensurate with the extent of their participation.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 ANCC contact hours.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 0.25 contact hours.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

Additional Content Planners

Lauren Mangan, PharmD, BCCCP (Planner)
No significant relationships to disclose.

Gregory Scott, PharmD, RPh (Planner)
No significant relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Presenting Faculty

  • Christopher Flores, MD

    Family Medicine Physician
    Eisenhower Medical Center
    Rancho Mirage, California

  • Jennalyn D. Mayeux, DNP, FNP-C headshot

    Jennalyn D. Mayeux, DNP, FNP-C

    Nurse Practitioner
    Pulmonary Hypertension & Dyspnea Program
    University of Utah
    Salt Lake City, Utah

  • LaTosha Mollette, DNP

    Family Nurse Practitioner
    Louisiana Family Medicine Clinic
    Jonesboro, Louisiana

  • Michael Smith, PharmD

    Clinical Pharmacist in Pain/Palliative Care
    University of Michigan
    Ann Arbor, Michigan

  • Aaron B. Waxman, MD, PhD headshot

    Aaron B. Waxman, MD, PhD

    Associate Professor of Medicine
    Harvard Medical School
    Director, Pulmonary Vascular Disease Program
    Brigham and Women’s Hospital
    Boston, Massachusetts

Learning Objectives

  • Describe the evolution in the treatment landscape for patients with pulmonary arterial hypertension
  • Identify strategies to improve interprofessional care of patients with pulmonary arterial hypertension

Faculty Disclosures

Christopher Flores, MD

No relationships to disclose.

Jennalyn D. Mayeux, DNP, FNP-C

Advisory Board: Gossamer Bio, Liquidia

Consultant: Gossamer Bio, Johnson & Johnson, Merck

Speakers Bureau: Johnson & Johnson, Liquidia, Merck, United Therapeutics


LaTosha Mollette, DNP

No relationships to disclose.

Michael Smith, PharmD

No relationships to disclose.

Aaron B. Waxman, MD, PhD

Consultant: Merck, OrphAI, Tectonic, United Therapeutics

Data Monitoring Safety Board: INSMED